Externally‐Led Patient‐Focused Drug Development Meeting (EL‐PFDD) for Dementia with Lewy Bodies—DLB: Voices of Lived Experience on Life with Lewy and Unmet Treatment Needs
The EL-PFDD on DLB provided valuable information for drug developers and regulators to understand the lived experience of people with DLB and care partners. The results will be documented in a "Voice of the Patient" report that will be hosted at www.lbda.org/el-pfdd.
Authors
- Kimberly Pfleeger
- Sam Fazio (ORCID: https://orcid.org/0000-0002-5408-4241)
- Lycia Tramujas Vasconcellos Neumann (ORCID: https://orcid.org/0000-0001-7875-0336)
- Keith N. Fargo (ORCID: https://orcid.org/0000-0002-6515-2342)
- Deborah Walter (ORCID: https://orcid.org/0000-0002-0350-6280)
- Angela Taylor (ORCID: https://orcid.org/0000-0003-2001-3776)
- Helen Bundy Medsger
- Jonathan Stokes
- James Valentine (ORCID: https://orcid.org/0000-0002-6670-3775)
- Barbara Levine
- Brad F Boeve
- James E. Galvin
- Glorieuse Pugh
- Guttmacher Laurence
- Melissa J. Armstrong
- Elizabeth Rachchh
- Larry J. Bauer
- Marwan N. Sabbagh
Institutions
- Alzheimer's Association (US)
- Barrow Neurological Institute (US)
- AARP (US)
- University of Miami (US)
- General Electric (Spain) (ES)
- AbbVie (United States) (US)
- University of Florida (US)
- Partners In Care (US)
- Mayo Clinic in Arizona (US)
- Pro Persona (NL)
- University of Rochester (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70859_104394
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00